Ivor Harrison has been appointed the Managing Director of Phynova the innovative life science company that develops proprietary drugs and functional ingredients from active compounds found in plants, based in Oxford. Ivor has significant experience in the FMCG Food and drinks market and has occupied several senior roles, formerly CEO of William Ransom & Son and Managing Director of and Maximuscle, the UK’s leading sports nutrition company.
Executive Chairman, Robert Miller, commented: “Phynova has had a very positive six months and we are pleased to be adding to this by bringing in a Managing Director of Ivor’s calibre. His considerable experience of building brands and his knowledge of the healthcare and FMCG sectors will complement the existing Phynova team, and will help us continue with our corporate development. Ivor has the required skills and know-how to take advantage of the significant opportunities the EU THMP Directive has given us and I look forward to his leadership in the day-to-day running and growth of Phynova.”
Phynova Managing Director, Ivor Harrison said: “I am very pleased to become part of Phynova, which is a company I have followed for many years. Their work in the field of healthcare is pioneering, as demonstrated by gaining the MHRA’s first approval in the UK for a traditional Chinese medicine (TCM), Phynova Joint and Muscle Relief Tablets™. They have a clear strategy in place to develop both the business and the commercialisation of their impressive pipeline, and I look forward to being part of the team to deliver on this growth plan.”